General Information of the Compound
Compound ID
CP0179579
Compound Name
1-[2-(2-Benzyl-phenoxy)-ethyl]-pyrrolidine
    Show/Hide
Synonyms
1-[2-(2-Benzyl-phenoxy)-ethyl]-pyrrolidine
BDBM50151045
CHEMBL435505
    Show/Hide
Structure
Formula
C19H23NO
Molecular Weight
281.399
Canonical SMILES
C(CN1CCCC1)Oc1ccccc1Cc1ccccc1
    Show/Hide
InChI
InChI=1S/C19H23NO/c1-2-8-17(9-3-1)16-18-10-4-5-11-19(18)21-15-14-20-12-6-7-13-20/h1-5,8-11H,6-7,12-16H2
    Show/Hide
InChIKey
MNZXCYDDVWTITD-UHFFFAOYSA-N
Physicochemical Property
logP
3.752
Rotatable Bonds
6
Heavy Atom Count
21
Polar Areas
12.47
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
2
Complexity
21

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 44396235
ChEMBL ID
CHEMBL435505
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01206, Histamine H1 receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000025 HEK-293T Homo sapiens (Human)  1
1
Ki = 15.85 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( 1-[2-(2-Benzyl-phenoxy)-ethyl]-pyrrolidine )
Drug Name 1-[2-(2-Benzyl-phenoxy)-ethyl]-pyrrolidine
Target(s)
Dopamine D3 receptor (D3R)
Inhibitor
Dopamine D5 receptor (D5R)
Inhibitor
Dopamine D1 receptor (D1R)
Inhibitor
Dopamine D4 receptor (D4R)
Inhibitor